# TearCare System to Treat Dry Eye Disease

> **NCT03857919** · NA · COMPLETED · sponsor: **Sight Sciences, Inc.** · enrollment: 235 (actual)

## Conditions studied

- Dry Eye
- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** TearCare
- **DEVICE:** LipiFlow

## Key facts

- **NCT ID:** NCT03857919
- **Lead sponsor:** Sight Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-03
- **Primary completion:** 2020-02-17
- **Final completion:** 2020-12-18
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2025-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03857919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03857919, "TearCare System to Treat Dry Eye Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03857919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*